CHU de Dijon, Service de dermatologie

Dijon

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Progressive Brain Metastasis, Unresectable or Metastatic Melanoma

Studies at this site

• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed